EUVIMEDOpdag EUVIMED
Open access · CC BY-NC 4.0

Genome‐wide analyses reveal novel opioid use disorder loci and genetic overlap with schizophrenia, bipolar disorder, and major depression

Børge Holen iD, Alexey A Shadrin, Romain Icick iD, Tahir T Filiz, Guy Hindley, Linn Rødevand, Kevin S O'Connell, Espen Hagen, Oleksandr Frei, Shahram Bahrami, Weiqiu Cheng, Nadine Parker and 7 more

Addiction Biology · 2023

DOI: 10.1111/adb.13282 ↗

At a glance

Journal article in Addiction Biology, 2023. Written by Børge Holen and 18 co-authors. Institution: NORMENT, Institute of Clinical Medicine, Division of Mental Health and Addiction, Oslo University Hospital, University of Oslo, Oslo, Norway. Major MEDLINE topics: Bipolar Disorder, Major Depressive Disorder, Schizophrenia. Cited 18 times so far (Crossref); 68 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: NIA NIH HHS, NIMH NIH HHS, NIDA NIH HHS.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Opioid use disorder (OUD) and mental disorders are often comorbid, with increased morbidity and mortality. The causes underlying this relationship are poorly understood. Although these conditions are highly heritable, their shared genetic vulnerabilities remain unaccounted for. We applied the conditional/conjunctional false discovery rate (cond/conjFDR) approach to analyse summary statistics from independent genome wide association studies of OUD, schizophrenia (SCZ), bipolar disorder (BD) and major depression (MD) of European ancestry. Next, we characterized the identified shared loci using biological annotation resources. OUD data were obtained from the Million Veteran Program, Yale‐Penn and Study of Addiction: Genetics and Environment (SAGE) (15 756 cases, 99 039 controls). SCZ (53 386 cases, 77 258 controls), BD (41 917 cases, 371 549 controls) and MD (170 756 cases, 329 443 controls) data were provided by the Psychiatric Genomics Consortium. We discovered genetic enrichment for OUD conditional on associations with SCZ, BD, MD and vice versa, indicating polygenic overlap with identification of 14 novel OUD loci at condFDR < 0.05 and 7 unique loci shared between OUD and SCZ ( n = 2), BD ( n = 2) and MD ( n = 7) at conjFDR < 0.05 with concordant effect directions, in line with estimated positive genetic correlations. Two loci were novel for OUD, one for BD and one for MD. Three OUD risk loci were shared with more than one psychiatric disorder, at DRD2 on chromosome 11 (BD and MD), at FURIN on chromosome 15 (SCZ, BD and MD) and at the major histocompatibility complex region (SCZ and MD). Our findings provide new insights into the shared genetic architecture between OUD and SCZ, BD and MD, indicating a complex genetic relationship, suggesting overlapping neurobiological pathways.

Subjects

MeSH terms (MEDLINE)

Bipolar DisorderMajor Depressive DisorderSchizophreniaHumansGenome-Wide Association StudyDepressionGenetic Predisposition to DiseasePolymorphism, Single NucleotideGenetic Loci

Author keywords

bipolar disordergenetic overlapgenome-wide association study (GWAS)major depressionopioid use disorderschizophrenia

Authors and institutions

  • NORMENT, Institute of Clinical Medicine, Division of Mental Health and Addiction, Oslo University Hospital, University of Oslo, Oslo, Norway.
  • INSERM UMR-S1144, Paris University, Paris, France.
  • Department of Cognitive Science, University of California San Diego, La Jolla, California, USA.
  • Department of Radiology, University of California San Diego, La Jolla, California, USA.
  • Multimodal Imaging Laboratory, University of California San Diego, La Jolla, California, USA.
  • Department of Psychiatry, University of California San Diego, La Jolla, California, USA.

ORCID profiles: Børge Holen, Romain Icick, Markos Tesfaye

Funding

  • NIA NIH HHS
  • NIMH NIH HHS
  • NIDA NIH HHS
  • Norges Forskningsråd
  • Helse Sør-Øst RHF
  • Horizon 2020 Framework Programme
  • Stiftelsen Kristian Gerhard Jebsen
  • Foundation for the National Institutes of Health

Cite

APA

Holen, B., Shadrin, A. A., Icick, R., Filiz, T. T., Hindley, G., Rødevand, L., O'Connell, K. S., Hagen, E., Frei, O., Bahrami, S., Cheng, W., Parker, N., Tesfaye, M., Jahołkowski, P., Karadag, N., Dale, A. M., Djurovic, S., Smeland, O. B., & Andreassen, O. A. (2023). Genome‐wide analyses reveal novel opioid use disorder loci and genetic overlap with schizophrenia, bipolar disorder, and major depression. Addiction Biology. https://doi.org/10.1111/adb.13282

Vancouver

Holen B, Shadrin AA, Icick R, Filiz TT, Hindley G, Rødevand L, et al. Genome‐wide analyses reveal novel opioid use disorder loci and genetic overlap with schizophrenia, bipolar disorder, and major depression. Addiction Biology. 2023. doi:10.1111/adb.13282

BibTeX
@article{Holen2023,
  author = {Holen, Børge and Shadrin, Alexey A and Icick, Romain and Filiz, Tahir T and Hindley, Guy and Rødevand, Linn and O'Connell, Kevin S and Hagen, Espen and Frei, Oleksandr and Bahrami, Shahram and Cheng, Weiqiu and Parker, Nadine and Tesfaye, Markos and Jahołkowski, Piotr and Karadag, Naz and Dale, Anders M and Djurovic, Srdjan and Smeland, Olav B and Andreassen, Ole A},
  title = {Genome‐wide analyses reveal novel opioid use disorder loci and genetic overlap with schizophrenia, bipolar disorder, and major depression},
  journal = {Addiction Biology},
  year = {2023},
  doi = {10.1111/adb.13282}
}
Start for free →